News
-
-
PRESS RELEASE
Datavault AI CEO Nathaniel T. Bradley to Deliver Flagship Keynotes on Breakthrough RWA Tokenization at CONV3RGENCE London and AssetRush × Zurich 2026
Datavault AI Inc. announces CEO Nathaniel T. Bradley's keynote presentations at CONV3RGENCE London & AssetRush Zurich 2026, showcasing RWA tokenization technologies ahead of XRP Tokyo event -
REGULATED PRESS RELEASE
FinanceWire Introduces Certidox to Enable Verifiable Press Releases as Fake Content Becomes Indistinguishable from Reality
FinanceWire launches Certidox to ensure verifiable press releases amid rising AI-generated fake content. Certidox QR codes enable instant verification of authenticity and status -
-
PRESS RELEASE
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.803 Million Tokens, and Total Crypto and Total Cash Holdings of $11.4 Billion
Bitmine Immersion Technologies (BMNR) announces ETH holdings reach 4.803 million tokens and total crypto and total cash holdings of $11.4 billion. Bitmine approved for uplisting to NYSE from NYSE American -
PRESS RELEASE
DeFi Technologies Announces Shareholder Call to Discuss Record 2025 Financial Results with Revenue of $99.1 Million and Net Income of $62.7 Million
DeFi Technologies announces record 2025 financial results with $99.1M revenue and $62.7M net income. Shareholder call scheduled for April 7, 2026, to discuss performance -
-
PRESS RELEASE
Revolve Signs Interconnection Agreement for 130 MW EL 24 Wind Project in Mexico
Revolve Renewable Power announces final interconnection agreement with CFE for 130MW wind project in Mexico, reaching key development milestone. Company focuses on project optimization and commercial strategies -
-
PRESS RELEASE
K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate Demonstrates Tumor-Selective Pharmacokinetics, Extensive Intratumoral Distribution and Superior Efficacy in Non-Clinical Animal Models
Kowa Company Ltd. to present non-clinical data for novel antibody drug-loaded unimicelle conjugate K-679 at AACR Annual Meeting 2026 showcasing tumor-selective pharmacokinetics